Request Demo
Last update 01 Nov 2025
FFP-104
Last update 01 Nov 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms FFP 104, FFP104, FFP104-001 |
Target |
Action inhibitors |
Mechanism CD40 inhibitors(Tumor necrosis factor receptor superfamily member 5 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 14032085
Sequence Code 15730973
Related
2
Clinical Trials associated with FFP-104NCT02465944
A Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group Pilot Study to Evaluate the Safety and Efficacy of FFP104 in the Treatment of Subjects With Moderate to Severely Active Crohn's Disease
NCT02193360
A Phase I/II, Open Label, Multicenter, Pilot Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacodynamics of FFP104 in Subjects Previously Diagnosed With Primary Biliary Cirrhosis (PBC)
100 Clinical Results associated with FFP-104
Login to view more data
100 Translational Medicine associated with FFP-104
Login to view more data
100 Patents (Medical) associated with FFP-104
Login to view more data
100 Deals associated with FFP-104
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Crohn Disease | Phase 2 | Belgium | 01 Jan 2016 | |
| Crohn Disease | Phase 2 | Netherlands | 01 Jan 2016 | |
| Primary Biliary Cholangitis | Phase 2 | Netherlands | 01 May 2015 | |
| Primary Biliary Cholangitis | Phase 2 | United Kingdom | 01 May 2015 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free